Yuvraj_pawp, Author at Pharma Advancement

Novartis announces positive phase III PARADIGMS study of Gilenya vs. interferon beta-1a in children & adolescents with MS

31st October 2017

Novartis has announced full results from the positive phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod)...

ORIC Pharma begins phase 1 study of novel GR antagonist with planned development for oncology

by Yuvraj_pawp

31st October 2017

ORIC Pharmaceuticals, a privately held oncology company focused on the discovery and development of drugs to address treatment resistant cancers,...

Bayer leads the way in modern development standards for evidence-based phytomedicine with Iberogast

by Yuvraj_pawp

30th October 2017

As consumer demand for herbal medicine continues to grow, the healthcare industry is under increasing pressure to demonstrate how plant-based...

Bayer receives FDA approval for Xarelto 10 mg once daily for the extended treatment of venous thromboembolism

by Yuvraj_pawp

30th October 2017

Bayer AG and its development partner Janssen Research & Development, LLC advise that the U.S. Food and Drug Administration (FDA)...

Boehringer Ingelheim achieves major breakthrough in canine cardiology

by Yuvraj_pawp

30th October 2017

Dogs suffering from cardiovascular disease and related clinical signs will officially have an opportunity for a better and longer life,...

Meta-Analysis Using Real-World Data Evaluates Safety Profile of Entyvio® (vedolizumab) in Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

by Yuvraj_pawp

30th October 2017

Takeda Pharmaceutical Company Limited announced the presentation of real-world evidence from two analyses evaluating the safety profile of Entyvio® (vedolizumab),...

Allergan Receives Approval for Ozurdex in China for the Treatment of Retinal Vein Occlusion (RVO)

by Yuvraj_pawp

30th October 2017

Allergan plc announced that it has received an Imported Drugs License (IDL) from the Chinese FDA to market Ozurdex® (dexamethasone...

Astellas Partners with CNBC for its Global Branding Campaign

by Yuvraj_pawp

30th October 2017

Astellas Pharma Inc. announced the next installment of its global corporate branding initiative, which it is conducting in collaboration with...

Astellas Oncology Selects Five C3 Prize® Finalists to Pitch Ideas for Changing Cancer Care at the UICC

by Yuvraj_pawp

30th October 2017

Astellas announced the five C3 Prize finalists chosen from more than 160 entries to present their ideas to change cancer...

Biogen And Eisai Expand Existing Collaboration Agreement To Develop And Commercialize Investigational for Alzheimer’s Disease Treatments

by Yuvraj_pawp

30th October 2017

Eisai Co., Ltd. and Biogen Inc. announced that the companies have expanded their existing agreement to jointly develop and commercialize...

Page 16 of 106 Prev 1 … 15 16 17 … 106 Next

New Method of Drug Value: Incorporating Real-World Data

AI And The Future of Drug Discovery And Manufacturing

AI Technology Transforming Pharmaceutical Route Scouting

Advancing Biologics : New Drug Delivery Methods In Focus

Nanoparticles : Next Frontier In Pharmaceutical Innovations

Nickel Complex Innovations Streamlines Drug Development

Streamlining Toxicology Materials For IND And FIH Studies

Booming Radiopharmaceuticals Industry Attracts Investors

FDA Grants Breakthrough Status To GSKs Lung Cancer Drug

New Method of Drug Value: Incorporating Real-World Data

AI And The Future of Drug Discovery And Manufacturing

AI Technology Transforming Pharmaceutical Route Scouting

Advancing Biologics : New Drug Delivery Methods In Focus

Nanoparticles : Next Frontier In Pharmaceutical Innovations

Nickel Complex Innovations Streamlines Drug Development

Streamlining Toxicology Materials For IND And FIH Studies

Booming Radiopharmaceuticals Industry Attracts Investors

FDA Grants Breakthrough Status To GSKs Lung Cancer Drug

Yuvraj_pawp

Novartis announces positive phase III PARADIGMS study of Gilenya vs. interferon beta-1a in children & adolescents with MS

ORIC Pharma begins phase 1 study of novel GR antagonist with planned development for oncology

Bayer leads the way in modern development standards for evidence-based phytomedicine with Iberogast

Bayer receives FDA approval for Xarelto 10 mg once daily for the extended treatment of venous thromboembolism

Boehringer Ingelheim achieves major breakthrough in canine cardiology

Meta-Analysis Using Real-World Data Evaluates Safety Profile of Entyvio® (vedolizumab) in Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

Allergan Receives Approval for Ozurdex in China for the Treatment of Retinal Vein Occlusion (RVO)

Astellas Partners with CNBC for its Global Branding Campaign

Astellas Oncology Selects Five C3 Prize® Finalists to Pitch Ideas for Changing Cancer Care at the UICC

Biogen And Eisai Expand Existing Collaboration Agreement To Develop And Commercialize Investigational for Alzheimer’s Disease Treatments

Latest News

Scalability and therapeutic potential of induced pluripotent reprogramming and neural induction using small molecules

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies – Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

Nutraceuticals 2025 takes position on international trade fair calendar, with fair slated for 5th and 6th March at new venue

UK Medicine Manufacturing Regulatory Framework For Care

Nanoemulsion Drug Delivery Enhances Tuberculosis Care

About Us

Qucik Links

Resources

System

Retrieve your password